TGO 93 commences the day after it is registered on the Federal Register of Legislation (section 2 of TGO 93). All medicinal cannabis products imported or supplied in Australia must conform with TGO 93 from its commencement, unless you have been given a consent by the Secretary.
Amendments to the version of TGO 93 registered in 2019 were made in March 2022. These amendments are subject to transition periods to allow industry to make changes to their products.
Sections 13, 14, 15 and 16 are subject to a transition period. All medicinal cannabis products released for supply in Australia on or after 1 July 2023 must comply with these requirements.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.